(Q35038459)

5 August 2017

1 reference

title

Aspergillosis. Pathogenesis, clinical manifestations, and therapy (English)

1 reference

5 August 2017

0 references

0 references

3

1 reference

5 August 2017

2

Thomas Patterson

1 reference

5 August 2017

1

Kieren A Marr

1 reference

5 August 2017

publication date

1 December 2002

1 reference

Infectious Disease Clinics of North America

5 August 2017

published in

1 reference

5 August 2017

volume

16

1 reference

5 August 2017

issue

4

1 reference

5 August 2017

page(s)

875-94, vi

1 reference

Acquired immunity in experimental murine aspergillosis is mediated by macrophages.

5 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Kinetic study of host defense and inflammatory response to Aspergillus fumigatus in steroid-induced immunosuppressed mice

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

In vivo bronchoalveolar macrophage defense against Rhizopus oryzae and Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Binding of rat and human surfactant proteins A and D to Aspergillus fumigatus conidia.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Mannose-binding lectin gene polymorphisms as a susceptibility factor for chronic necrotizing pulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Selective protection against conidia by mononuclear and against mycelia by polymorphonuclear phagocytes in resistance to Aspergillus. Observations on these two lines of defense in vivo and in vitro with human and mouse phagocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

T cell vaccination in mice with invasive pulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Cytokine- and T helper-dependent lung mucosal immunity in mice with invasive pulmonary aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Th1 and Th2 cytokines in mice with invasive aspergillosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Pathogenesis of pulmonary aspergillosis. Granulocytopenia versus cyclosporine and methylprednisolone-induced immunosuppression

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Participation of complement in the phagocytosis of the conidia of Aspergillus fumigatus by human polymorphonuclear cells

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Cell surface properties of Aspergillus fumigatus conidia: correlation between adherence, agglutination, and rearrangements of the cell wall

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Expression and identification of a laminin-binding protein in Aspergillus fumigatus conidia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Interaction of human phagocytes with pigmentless Aspergillus conidia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Cloning and disruption of the antigenic catalase gene of Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillus fumigatus catalases: cloning of an Aspergillus nidulans catalase B homologue and evidence for at least three catalases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Purification, N-Terminal Amino Acid Sequence and Partial Characterization of A Cu,Zn Superoxide Dismutase From the Pathogenic FungusAspergillusfumiga Tus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Isolation and characterisation of an extracellular alkaline protease of Aspergillus fumigatus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

The alkaline protease of Aspergillus fumigatus is not a virulence determinant in two murine models of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Epidemiology and outcome of mould infections in hematopoietic stem cell transplant recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Antifungal drug resistance in Aspergillus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus, with a head-to-head comparison to voriconazole.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Fatal disseminated infection with Aspergillus terreus in immunocompromised hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillus nidulans Infection in Chronic Granulomatous Disease

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Epidemiology ofAspergillusInfections in a Large Cohort of Patients Undergoing Bone Marrow Transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillus terreus infections in haematological malignancies: molecular epidemiology suggests association with in-hospital plants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Development of immune responses to Aspergillus at an early age in children with cystic fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Allergic bronchopulmonary aspergillosis in the asthma clinic. A prospective evaluation of CT in the diagnostic algorithm.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Clinical and immunologic criteria for the diagnosis of allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Antifungal therapies for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

T cell subsets, epitope mapping, and HLA-restriction in patients with allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Fungal allergens and peptide epitopes

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillus fumigatus peptides differentially express Th1 and Th2 cytokines

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Evidence for the involvement of two different MHC class II regions in susceptibility or protection in allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

1 reference

7 January 2021

A randomized trial of itraconazole in allergic bronchopulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Sarcoidosis and aspergilloma. The role of surgery

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Clinical evaluation of 61 patients with pulmonary aspergilloma

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Invasive pulmonary aspergillosis in AIDS: radiographic, CT, and pathologic findings.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillomas complicating sarcoidosis. A prospective study in 100 patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Allergic bronchopulmonary aspergillosis with coexistent aspergilloma: a long-term followup

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Surgical treatment for pulmonary aspergilloma: a 28 year experience.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Chronic forms of pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Halo sign on high resolution CT: findings in spectrum of pulmonary diseases with pathologic correlation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Practice guidelines for diseases caused by Aspergillus. Infectious Diseases Society of America

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Allergic fungal sinusitis: a four-year follow-up.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Allergic fungal sinusitis: Allergic, infectious, or both?

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Characteristics of bony erosion in allergic fungal rhinosinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Report of successful prolonged antifungal therapy for refractory allergic fungal sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Comprehensive management of allergic fungal sinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Chronic invasive fungal rhinosinusitis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Diagnostic accuracy in sinus fungus balls: CT scan and operative findings

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Fungus balls of the paranasal sinuses

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Sinus surgery in bone marrow transplantation patients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Nosocomial invasive aspergillosis in lymphoma patients treated with bone marrow or peripheral stem cell transplants

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Fungal sinusitis in immunocompromised children with neoplasms

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Invasive aspergillosis in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Pseudomembranous tracheobronchitis caused by Aspergillus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Pulmonary aspergillosis in the acquired immunodeficiency syndrome

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Ulcerative and plaque-like tracheobronchitis due to infection with Aspergillus in patients with AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Osteomyelitis of the base of the skull secondary to Aspergillus

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Invasive aspergillosis in patients with acquired immunodeficiency syndrome: report of 33 cases. French Cooperative Study Group on Aspergillosis in AIDS.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillus laryngotracheobronchial infection in a 6-year-old girl following bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Acute airway obstruction due to necrotizing tracheobronchial aspergillosis in immunocompromised patients: a new clinical entity

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Invasive aspergillosis of the lung and pericardium in a nonimmunocompromised 33 year old man

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Invasive pulmonary aspergillosis in nonimmunocompromised, nonneutropenic hosts

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Fulminant tracheobronchial and pulmonary aspergillosis complicating imported Plasmodium falciparum malaria in an apparently immunocompetent woman

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillosis in a Healthy Host

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Ulcerative tracheobronchitis after lung transplantation. A new form of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Spectrum of Aspergillus infection in lung transplant recipients: case series and review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Topical amphotericin B application in severe bronchial aspergillosis after lung transplantation: report of experiences in 3 cases

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Significant reduction in the number of fungal infections after lung-, heart-lung, and heart transplantation using aerosolized amphotericin B prophylaxis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Trends in the postmortem epidemiology of invasive fungal infections at a university hospital

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Invasive mold infections in allogeneic bone marrow transplant recipients.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Incidence and risk factors for invasive fungal infections in allogeneic BMT recipients

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Invasive aspergillosis in allogeneic stem cell transplant recipients: changes in epidemiology and risk factors.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Fungal pulmonary infections after bone marrow transplantation: evaluation with radiography and CT.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Increasing volume and changing characteristics of invasive pulmonary aspergillosis on sequential thoracic computed tomography scans in patients with neutropenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

The use of respiratory-tract cultures in the diagnosis of invasive pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Autopsy-controlled prospective evaluation of serial screening for circulating galactomannan by a sandwich enzyme-linked immunosorbent assay for hematological patients at risk for invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Screening for circulating galactomannan as a noninvasive diagnostic tool for invasive aspergillosis in prolonged neutropenic patients and stem cell transplantation recipients: a prospective validation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Comparison between PCR and detection of antigen in sera for diagnosis of pulmonary aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillus fungemia: report of two cases and review

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Significance of aspergillemia in patients with cancer: a 10-year study

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Itraconazole oral solution for primary prophylaxis of fungal infections in patients with hematological malignancy and profound neutropenia: a randomized, double-blind, double-placebo, multicenter trial comparing itraconazole and amphotericin B.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Itraconazole oral solution as prophylaxis for fungal infections in neutropenic patients with hematologic malignancies: a randomized, placebo-controlled, double-blind, multicenter trial. GIMEMA Infection Program. Gruppo Italiano Malattie Ematologiche

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

A randomized controlled trial of itraconazole versus fluconazole for the prevention of fungal infections in patients with haematological malignancies. U.K. Multicentre Antifungal Prophylaxis Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopenia

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Liposomal amphotericin B for empirical therapy in patients with persistent fever and neutropenia. National Institute of Allergy and Infectious Diseases Mycoses Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Voriconazole compared with liposomal amphotericin B for empirical antifungal therapy in patients with neutropenia and persistent fever

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

NIAID Mycoses Study Group Multicenter Trial of Oral Itraconazole Therapy for Invasive Aspergillosis

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Analysis of compassionate use itraconazole therapy for invasive aspergillosis by the NIAID Mycoses Study Group criteria.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Invasive aspergillosis. Disease spectrum, treatment practices, and outcomes. I3 Aspergillus Study Group

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Aspergillosis case-fatality rate: systematic review of the literature

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Survival and prognostic factors of invasive aspergillosis after allogeneic bone marrow transplantation

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Management of invasive pulmonary aspergillosis in hematology patients: a review of 87 consecutive cases at a single institution

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

Impact of previous aspergillosis on the outcome of bone marrow transplantation.

1 reference

https://api.crossref.org/works/10.1016%2FS0891-5520%2802%2900035-1

7 January 2021

10.1016/S0891-5520(02)00035-1

Identifiers

DOI

1 reference

5 August 2017

1 reference